ISSN: 2459 - 1777 | E-ISSN 2587-0394
Volume: 4
Issue: 2
Year: 2019

Instructions for Authors

This journal uses JournalAgent to double blind peer-review manuscript submissions. Please read the guide for JournalAgent authors before making a submission. Complete guidelines for preparing and submitting your manuscript to this journal are provided below.

All authors’ ORCID numbers need to be submitted when creating an account for correspondence. To obtain an ORCID number, please visit:

Manuscripts must be submitted through the journal’s website Paper manuscript submissions are not accepted. Full-length papers comprise the major part of each issue. Reviews are accepted for publication only at the invitation of the Editors.

It is the responsibility of the authors to ensure that the English used in their manuscript is correct, both grammatically and stylistically, before submission.

Beyoglu Eye Journal strives to publish papers of high quality regarding clinical research, epidemiology, anatomy, biophysics, biochemistry, developmental biology, microbiology, and immunology related to the eye and vision.

There is no fee for article submission, article processing or publication.

Policy of screening for plagiarism
The manuscripts are scanned by the Publisher’s Office using the iThenticate program for determination of plagiarism and non-ethical situations.

Open Access
Beyoglu Eye Journal is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.

Commons User Licenses
Creative Commons Attribution-NonCommercial (CC BY-NC) For non-commercial purposes, lets others distribute and copy the article, and to include in a collective work, as long as they credit the author(s) and provided they do not alter or modify the article.

Publishing Ethics
The Editors and Kare Publishing are committed to upholding the highest academic, professional, legal, and ethical standards in the publication of this journal. To this end, we have adopted a set of guidelines, to which all submitting authors are expected to adhere, to assure integrity and ethical publishing for authors, reviewers, and editors.

The publisher, Kare Publishing, is a member of the Committee of Publications Ethics (COPE). COPE aims to provide a forum for publishers and editors of scientific journals to discuss issues related to the integrity of their work, including conflicts of interest, falsification and fabrication of data, ethical misconduct, unethical experimentation, inadequate patient consent, and authorship disputes. For more information on COPE please visit

Length of Manuscripts: The maximum word count and illustrations including tables is:
Full Papers: 5000 words, 8 illustrations / tables
Case Reports: 3500 words, 5 illustrations / tables, max 6 authors
Short Communications: 1500 words, 4 illustrations / tables, max 2 authors
Reviews: 7000 words, 10 illustrations / tables
Case Reports: 4000 words, 8 illustrations / tables
Surgical Techniques: 4000 words, 8 illustrations / tables, max 3 authors

Authors who wish to contribute a review should first contact one of the editors-in-chief, Muhittin Taskapili (

The journal accepts letters (not to exceed 750 words) only if they concern articles already published in Beyoglu Eye Journal. (max 2 authors).

Announcements of forthcoming meetings, courses, etc., may be published. The editors will also consider special issues containing papers on topics of focus or from a conference.

Each manuscript must be accompanied by a statement indicating that it has not been published elsewhere and that it has not been submitted simultaneously for publication elsewhere. Beyoglu Eye Journal follows the guidelines of the International Committee of Medical Journal Editors, which generally prohibits duplicate publication ( is also the responsibility of the lead or corresponding author to indicate on the manuscript title page whether a commercial relationship existed in the form of financial support or personal financial interest. Financial support includes support from a for-profit company in the form of research funding.

Authors are responsible for obtaining permission to reproduce copyrighted material from other sources and are required to sign an agreement for the transfer of copyright to the publisher. As an author, you are required to secure permission if you want to reproduce any figure, table, or extract text from any other source. This applies to direct reproduction as well as "derivative reproduction" (such as when you have created a new figure or table which is derived substantially from a copyrighted source).

All accepted manuscripts, artwork, and photographs become the property of the publisher. All parts of the manuscript should be written in a clear font, such as Times New Roman or Arial, double-spaced, with margins of at least one inch on all sides. The main text and tables should be uploaded as Word documents. Do not include line numbers. Manuscript pages should be numbered consecutively throughout the paper.

Authors should provide a cover letter that includes the contact details of the corresponding author. Authors should briefly explain why their work is appropriate for Beyoglu Eye Journal.

Submissions need to be of sufficient editing quality that they will be easily interpreted by the readership of the Journal. If submitted work does not meet this standard, it will be returned to the authors. The Journal follows the AMA Manual of Style for manuscripts submitted to biomedical journals.
Case report: Introduction, case report, discussion.

Set your document as A4 paper, use double line spacing, Times font size 12, number all pages, do not justify the right margin, and do not use line numbers. Save your manuscript as a Word document (.doc, .docx, or previous).

Structure your manuscript file as follows: Title page, Abstract and key words, Text, Acknowledgments, References, Tables, Figure legends.

Title page. The first page (title page) of your manuscript file must include the following information:

  • Full title (max 150 characters including letters and spaces), which must be concise and informative.
  • Short title (max 75 characters, including letters and spaces).
  • All authors listed as first name, initials, and last name (i.e., Zeynep Alkin, MD) with highest academic or medical degree first.
  • Institutional affiliation of each author, using superscripts and not symbols (e.g., Alper Agca1).
  • Corresponding author’s information (full mailing address, phone and fax numbers, email address); this is usually the submitting author.
  • Clinical trial protocol number when submitting a clinical trial protocol.
  • Online-only supplementary material, with a short description.
Abstract. A structured abstract of no more than 350 words is to be provided, divided into the following sections: Purpose/Aim of the study, Materials and Methods, Results, and Conclusions. Avoid abbreviations, diagrams, and reference to the text in the abstract. At least three and maximum of six key words should be identified for indexing. List the key words beneath the abstract in alphabetical order. Use terms from the Medical Subject Headings list from lndex Medicus whenever possible. A library of terms is available at

Main Text. Divide the text into the following sections: Introduction, Methods, Results, and Discussion. Use commas (,) to separate thousands and full stop (.) for decimals (e.g. 12,354.55). Include tables in the manuscript file, after the references. Number all figures (graphs, charts, photographs, and illustrations) in the order of their citation in the text. Figures must be submitted as separate files and not embedded in the Word document.

Funding. List all sources of funding for the research.

Declaration of Interests. Declare any competing interests for each author. All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. It is the sole responsibility of authors to disclose any affiliation with any organization with a financial interest, direct or indirect, in the subject matter or materials discussed in the manuscript (such as consultancies, employment, paid expert testimony, honoraria, speakers bureaus, retainers, stock options or ownership, patents or patent applications or travel grants) that may affect the conduct or reporting of the work submitted. All sources of funding for research are to be explicitly stated. If uncertain as to what might be considered a potential conflict of interest, authors should err on the side of full disclosure.

All submissions to the journal must include full disclosure of all relationships that could be viewed as presenting a potential conflict of interest. If there are no conflicts of interest, authors should state that there are none. This must be stated at the point of submission (within the manuscript after the main text under a subheading "Declaration of interest" and where available within the appropriate field on the journal’s Manuscript Central site). This may be made available to reviewers and will appear in the published article at the discretion of the Editors or Publisher.

If no conflict is declared, the following statement will be attached to all articles: Declaration of interest. The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

The intent of this policy is not to prevent authors with these relationships from publishing work, but rather to adopt transparency such that readers can make objective judgments on conclusions drawn.


List in this section:
  • Any substantial contribution provided by a person other than the author and who does not fulfill authorship criteria
  • The assistance of medical writing experts
  • All participating group authors who do not meet the full authorship criteria
  • All sources of funding for the manuscript and the financial disclosures for all authors
Written permission must be obtained to include the names of all individuals included in the Acknowledgments section.

If the manuscript has been presented at a meeting, please indicate in this section name, location, and date of event.

References. References should be identified in the text with Arabic numerals and numbered in the order cited. All references should be compiled at the end of the article in the Vancouver style.

Authors are responsible for the accuracy and completeness of their references and for correct text citation. Personal communications, unpublished data, abstracts, and oral or poster presentations should be limited and incorporated in parentheses within the text without a reference number. Signed permission should be included from each individual identified in a personal communication or as a source for unpublished data, as well as the date of communication.

Authors are responsible for the accuracy and completeness of their references and for correct text citation. Personal communications, unpublished data, abstracts, and oral or poster presentations should be limited and incorporated in parentheses within the text without a reference number. A signed permission should be included from each individual identified in a personal communication or as a source for unpublished data, as well as the date of communication.
  • References should follow the text and begin on a separate page.
  • References must be double line spaced and numbered consecutively in order of appearance within the text, using the Word automated numbering tool.
  • Identify references in text, tables, and legends with Arabic numerals in parentheses, i.e., (5).
  • List all authors when six or fewer; when seven or more, list only the first three and add et al.
  • References used within tables or figure legends should be included in the reference list and numbered in consecutive order according to the table/figure citation in the text.
  • Journal names should be abbreviated according to Index Medicus/Medline. If there is any doubt about abbreviation of a journal name, it should be spelled out completely.
  • Any references to studies (including books or articles) that have been accepted for publication but are not yet published should indicate where they will be published and have the term “in press” in the reference in place of volume and page numbers. These must be updated prior to publication, if possible.
Journal article (print): Erdogan G, Unlu C, Gunay BO, Kardes E, Ergin A. Implantation of foldable posterior chamber intraocular lens in aphakic vitrectomized eyes without capsular support. Arq Bras Oftalmol. 2016;79:159-162.
Journal article (print, more than six authors): Ozkaya A, Alagoz C, Garip R, et al. The role of indocyanine angiography imaging in further differential diagnosis of patients with nAMD who are morphologically poor responders to ranibizumab in a real-life setting. Eye (Lond) 2016;30:958-65.

Book: Bill A, Maepea O. Mechanisms and Routes of Aqueous Humor Drainage. Philadelphia: WB Saunders; 1975.
Contribution to a Book: Farris RL. Abnormalities of the tears and treatment of dry eyes. In: Kaufman HE, Barron BA, McDonald MB, editors. The Cornea. 2nd ed. Boston, MA: Butterworth-Heinemann; 1998.

Tables and Figures. Tables and figures should not be embedded in the text, but should be included as separate sheets or files. A short descriptive title should appear above each table with a clear legend and any footnotes suitably identified below. All units must be included. Figures should be completely labeled, taking into account necessary size reduction..
Captions should be typed, double-spaced, on a separate sheet. All original figures should be clearly marked with the number, author’s name, and top edge indicated.

Illustrations. Illustrations submitted should be clean originals or digital files. Digital files are recommended for highest quality reproduction and should follow these guidelines:

300 dpi or higher sized to fit on journal page EPS, TIFF, or PSD format only submitted as separate files, not embedded in text files.

Page Proofs: All proofs must be corrected and returned to the publisher within 48 hours of receipt. If the manuscript is not returned within the allotted time, the editor will proofread the article and it will be printed per the editor’s instruction. Only correction of typographical errors is permitted.

Withdrawal Policy

Withdrawal of a manuscript will be permitted only for the most compelling and unavoidable reasons. For withdrawal of a manuscript authors need to submit an "Article withdrawal Form", signed by all authors mentioning the reason for withdrawal to the Editorial Office. The form is available from the web page of the journal. Authors must not assume that their manuscript has been withdrawn until they have received appropriate notification to this effect from the editorial office.

In a case where a manuscript has taken more than six months’ time for review process, that allows the author to withdraw manuscript.

Manuscript withdrawal penalty: After receiving the Article withdrawal Form, Beyoglu Eye Journal Editorial Board will investigate the reason of withdrawal.

If the reason finds to be acceptable, the author is allowed to withdraw the manuscript. If not Beyoglu Eye Journal will not accept any manuscripts from the same author for one year.

Important notes: Manuscripts may be withdrawn at any stage of review and publication process by submitting a request to the editorial office. Manuscript withdrawal will be permitted after submission only for the most compelling and unavoidable reasons.

If the author wants to withdraw a manuscript, the author needs to submit a completed "Article withdrawal Form", signed by all authors of the manuscript stating the reasons for manuscript withdrawal. The form is available from the web page of the journal.

The manuscript will not be withdrawn from publication process until a completed, signed form is received by the editorial office. Authors must not assume that their manuscript has been withdrawn until they have received appropriate notification to this effect from the Beyoglu Eye Journal editorial office.

Copyright 2019 Beyoglu Eye Journal LookUs & Online Makale